Starting TRT online: what the science says vs. the hype

What did @kmartfit actually say?

The creator, promoting a service they called "Harley-Beds" (almost certainly Harley Meds), claims that patients can go from an initial consultation call to testosterone delivered at their door in "five to seven business days" with existing bloodwork, or "seven to ten business days" if bloodwork is still needed. They also lean on personal experience, saying they know "what it feels like to have low testosterone."

This is an affiliate-style promotional video. The creator directs viewers to comment "TRT" or click a bio link to get started. There is no mention of a physician evaluation, diagnostic criteria for hypogonadism, or what happens if a patient does not qualify. The framing is almost entirely about speed, not clinical appropriateness.

Does the science back this up?

The timelines are plausible on the logistics side, but the clinical picture is more complicated than the video suggests. Speed is not the problem. Skipping proper diagnosis is.

Clinical guidelines from the American Urological Association (AUA, 2018) and the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) require two separate morning fasting testosterone measurements on different days before a TRT diagnosis is confirmed. A single blood draw, which is what a fast-turnaround telehealth model typically relies on, does not meet that standard. Bhasin et al. also note that symptoms of low testosterone overlap heavily with depression, sleep apnea, obesity, and hypothyroidism, all of which need to be ruled out before starting exogenous testosterone. A five-to-seven-day pipeline is not long enough to do that responsibly in most cases.

On the logistics side, telehealth pharmacies can ship compounded testosterone cypionate quickly once a prescription is issued. That part is not fabricated.

What did they get wrong (or right)?

Credit where it is due: the frustration with slow traditional care is real. Studies have documented significant delays in men receiving treatment for confirmed hypogonadism through conventional healthcare (Coward et al., 2012, Journal of Urology). Telehealth can genuinely reduce that lag for patients who have already been properly evaluated.

What the creator got wrong is framing speed as an unambiguous benefit without any acknowledgment of why a slower process sometimes exists. The AUA and Endocrine Society guidelines exist because testosterone suppresses the hypothalamic-pituitary-gonadal axis, affects fertility, raises hematocrit, and carries cardiovascular considerations that require baseline labs beyond a single testosterone panel. The video mentions none of this. There is also no acknowledgment that "hormone optimization" for men with normal testosterone levels is not a recognized medical indication. Prescribing testosterone to someone without confirmed hypogonadism is off-label at best and potentially harmful at worst. The creator does not draw that line anywhere in this video.

What should you actually know?

If you are genuinely considering TRT, the timeline matters less than what happens during those days. Here is what proper evaluation actually involves.

• Two separate morning testosterone tests, ideally at least a week apart, both showing levels below approximately 300 ng/dL (the threshold varies by lab and guideline).
• A full panel including LH, FSH, prolactin, and a complete blood count to rule out secondary causes and establish a hematocrit baseline (Bhasin et al., 2018).
• A conversation about fertility, because exogenous testosterone suppresses sperm production and that effect is not always reversible quickly (Crosnoe et al., 2013, Fertility and Sterility).
• Cardiovascular risk screening, given ongoing debate about TRT and cardiac events, most recently addressed in the TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), which showed non-inferiority to placebo for major cardiac events in a specific population but did show increased rates of atrial fibrillation and pulmonary embolism.

A platform can technically hit a seven-day window and still do all of this. But the video gives you no reason to believe that is what is happening. You are being sold speed, not safety.